• Publications
  • Influence
Use of pharmacoeconomics information--report of the ISPOR Task Force on use of pharmacoeconomic/health economic information in health-care decision making.
OBJECTIVES Despite the growing number of pharmacoeconomic (PE)/health economic (HE) studies, very little is known about their use by decision makers. The objectives of the Task Force were to ensureExpand
  • 124
  • 6
  • PDF
“On‐the‐spot” vaccination
  • 2
Growth hormone use in transitioning patients--clinician and payer concerns.
Determining which patients with childhood-onset growth hormone (GH) deficiency will require continuing GH therapy into and/or throughout adulthood raises clinical and economic issues, such asExpand
  • 1